Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Fluorescent noninfectious agent antibody; titer, each antibody

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86256 refers to the laboratory test that measures the titer of antibodies against noninfectious agents using a fluorescent technique. This procedure is essential for identifying the presence of specific antibodies in a patient's blood sample or cerebral spinal fluid (CSF). The test is typically performed after an initial screening, which is coded under CPT® 86255, to determine if antibodies are present or elevated. The antibodies detected through this testing can indicate various medical conditions or the potential risk of developing certain disorders that are not caused by infectious agents. Examples of such conditions include celiac disease, premature ovarian failure, myasthenia gravis, and other autoimmune disorders. Additionally, this test can help assess exposure to environmental toxins that may lead to autoimmune diseases, certain cancers, graft versus host disease following organ transplants, and myocardial infarction or other forms of cardiac injury. Furthermore, the results from these antibody screenings and titers can serve as valuable markers for monitoring the effectiveness of immunosuppressant therapy in patients undergoing treatment for autoimmune conditions or following transplants.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 86256 is indicated for use in various clinical scenarios where the presence of antibodies to noninfectious agents needs to be assessed. The following conditions and situations warrant the performance of this test:

  • Celiac Disease - A condition where the ingestion of gluten leads to damage in the small intestine, often requiring antibody testing for diagnosis.
  • Premature Ovarian Failure - A condition characterized by the loss of normal ovarian function before age 40, which may involve autoimmune factors.
  • Myasthenia Gravis - An autoimmune disorder that affects communication between nerves and muscles, leading to weakness and fatigue.
  • Other Autoimmune Disorders - Various conditions where the immune system mistakenly attacks the body’s own tissues, necessitating antibody testing.
  • Exposure to Environmental Toxins - Situations where individuals may have been exposed to substances that could trigger autoimmune responses.
  • Cancers - Certain malignancies may be associated with specific antibody responses, making this test relevant for monitoring.
  • Graft vs. Host Disease - A complication following organ transplants where the donor's immune cells attack the recipient's body.
  • Myocardial Infarction and Other Cardiac Injury - Conditions affecting the heart that may be linked to autoimmune processes, warranting antibody evaluation.

2. Procedure

The procedure for CPT® Code 86256 involves several key steps to ensure accurate measurement of antibody titers. The following outlines the procedural steps:

  • Step 1: Sample Collection - A blood sample or cerebral spinal fluid (CSF) is obtained from the patient. Blood is typically collected through a venipuncture, while CSF is obtained via a lumbar puncture (spinal tap). Proper techniques must be followed to ensure sample integrity and minimize patient discomfort.
  • Step 2: Laboratory Processing - Once the sample is collected, it is sent to a laboratory where it undergoes processing. This may involve centrifugation to separate plasma or serum from blood cells, or specific handling protocols for CSF to preserve its components.
  • Step 3: Fluorescent Antibody Testing - The laboratory performs the fluorescent technique to detect the presence of antibodies against noninfectious agents. This involves adding specific antigens to the sample and using fluorescent markers to visualize any binding of antibodies.
  • Step 4: Titer Determination - If antibodies are detected, the laboratory will perform a titer count to quantify the level of antibodies present. This is done by serially diluting the sample and determining the highest dilution at which antibodies can still be detected.
  • Step 5: Reporting Results - The results of the test, including the presence and titer of antibodies, are compiled into a report. This report is then sent to the requesting physician for interpretation and further clinical decision-making.

3. Post-Procedure

After the procedure associated with CPT® Code 86256, patients may experience minimal discomfort, particularly if venipuncture or lumbar puncture was performed. It is important for healthcare providers to monitor patients for any immediate adverse reactions, especially following a lumbar puncture, which may include headache or back pain. Patients should be advised to rest and hydrate adequately post-procedure. The results of the antibody titer test will typically be available within a specified timeframe, allowing for timely clinical decisions regarding further management or treatment based on the findings. Additionally, healthcare providers may discuss the implications of the test results with the patient, including any necessary follow-up testing or interventions based on the identified antibody levels.

Short Descr FLUORESCENT ANTIBODY TITER
Medium Descr FLUORESCENT NONNFCT AGT ANTB TITER EA ANTIBODY
Long Descr Fluorescent noninfectious agent antibody; titer, each antibody
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 6 - Laboratory Physician Interpretation Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 9
CCS Clinical Classification 235 - Other Laboratory
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GC This service has been performed in part by a resident under the direction of a teaching physician
GA Waiver of liability statement issued as required by payer policy, individual case
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GW Service not related to the hospice patient's terminal condition
GZ Item or service expected to be denied as not reasonable and necessary
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
Q4 Service for ordering/referring physician qualifies as a service exemption
XP Separate practitioner, a service that is distinct because it was performed by a different practitioner
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
Date
Action
Notes
2011-01-01 Changed Short description changed. Guideline information changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"